Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
26 hedge funds and large institutions have $12.5M invested in Zosano Pharma Corporation in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
28% less capital invested
Capital invested by funds: $17.3M → $12.5M (-$4.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$309K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$227K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$213K |
| 4 |
BlackRock
New York
|
+$139K |
| 5 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
-$1.79M |
| 2 |
NC
Nexthera Capital
New York
|
-$120K |
| 3 |
G
Gainplan
Bloomfield Hills,
Michigan
|
-$82K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$62K |
| 5 |
Jane Street
New York
|
-$51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIM
26
Acrospire Investment Management
Chicago,
Illinois
| $2K | +$2.06K | +2 | New |
|
|
GTC
27
Ghost Tree Capital
New York
| – | -$1.79M | -1,343 | Closed |
|
|
G
28
Gainplan
Bloomfield Hills,
Michigan
| – | -$82K | -61 | Closed |
|
|
SSA
29
Schonfeld Strategic Advisors
New York
| – | -$62K | -47 | Closed |
|
|
30
Jane Street
New York
| – | -$51K | -38 | Closed |
|
ZSAN Hedge Fund Activity: Q2 2017 in Review
26 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2017, worth a combined $12.5M — down 28% from $17.3M a quarter earlier.
Fund positioning in ZSAN was balanced in Q2 2017: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $309K. The largest seller was Ghost Tree Capital, exiting entirely with an estimated $1.79M sold.
- 26 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $12.5M of Zosano Pharma Corporation stock for Q2 2017, down 28% quarter-over-quarter.
- 4 funds opened new Zosano Pharma Corporation positions in Q2 2017 and 4 closed out, a net change of 0 holders.
- The largest Zosano Pharma Corporation buyer in Q2 2017 was Vanguard Group, an estimated $309K added.
- The largest Zosano Pharma Corporation seller in Q2 2017 was Ghost Tree Capital, an estimated $1.79M sold.
Based on aggregated 13F filings for Q2 2017.